High and Varied Levels of Multidrug-Resistant Tuberculosis
Among isolates from patients with MDR-TB, 44% showed resistance to at least one second-line drug, and 7% were extensively resistant.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Activate your free online account for full access to all site content and features.
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)